Sort
40,608 grants matching “prostate cancer”
Development of Drugs Acting at Adenosine Receptors
$624,412Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed
$624,385Karen Conneely · Emory University · R01 · FY2024 · HL
Prostate cancer risk stratification via computational 3D pathology
$624,356Jonathan T.c. Liu · University Of Washington · R01 · FY2022 · CA
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
$624,299William C Hahn · Broad Institute, Inc. · R01 · FY2024 · CA
Drug Development for Prostate Cancer and other Metastatic Processes
$624,197William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Epidemiologic Architedure of Lung Cancer and Smoking
$624,146Christopher I. Amos · Dartmouth College · U19 · FY2012 · CA
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
$624,044Susan S. Eggly · Wayne State University · R01 · FY2016 · CA
Peptoid conjugates targeting prostate cancer
$624,001Michael J Garabedian · New York University School Of Medicine · R01 · FY2024 · CA
Development of Pirenzepine for CIPN
$623,955Andrew Mizisin · Winsantor, Inc. · R42 · FY2018 · CA
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
$623,916Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Administrative Core
$623,733Brian E Henderson · University Of Southern California · U19 · FY2011 · CA
African American Resilience in Surviving Cancer
$623,695Felicity Harper · Wayne State University · R01 · FY2020 · CA
African American Resilience in Surviving Cancer
$623,694Felicity Harper · Wayne State University · R01 · FY2021 · CA
African American Resilience in Surviving Cancer
$623,694Felicity Harper · Wayne State University · R01 · FY2019 · CA
Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer
$623,475Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2018 · CA
The roles of p53 in embryonic stem cells
$623,372Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
$623,355Shelley A. Johns · Indiana University Indianapolis · R01 · FY2023 · CA
Early clinial trials for Angelica herbal supplements for prostate cancer interception
$623,285Junxuan Lu · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Research Program
$623,251Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2023 · CA
Maryland Prostate Cancer Case-Control Study
$623,251Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Chemical Biology of the Control of Neddylation by DCN1
$623,225R Kiplin Guy · University Of Kentucky · R01 · FY2023 · CA
Transrectal Histotripsy for Focal Ablation of Prostate Cancer
$623,220George R Schade · University Of Washington · R01 · FY2022 · CA
Community-based Navigator Program for Cancer Control in African Americans
$623,179Chanita A Hughes-Halbert · University Of Pennsylvania · R01 · FY2008 · CA
Survivor QOL/Spouse Satisfaction after Prostate Therapy
$623,152Beth Israel Deaconess Medical Center · R01 · FY2005 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$623,145Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA